Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
New Hampshire Stocks
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Virpax Pharmaceuticals Inc
(NQ:
VRPX
)
0.8135
-0.0020 (-0.25%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Sep 4, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Virpax Pharmaceuticals Inc
< Previous
1
2
3
4
5
6
7
8
9
Next >
Virpax Pharmaceuticals Announces Reverse Stock Split to Regain Compliance with Nasdaq’s Minimum Bid Price
February 27, 2024
From
Virpax Pharmaceuticals, Inc.
Via
Business Wire
Virpax Pharmaceuticals Announces Proposed Settlement of Litigation with Sorrento Therapeutics, Inc. and Scilex Pharmaceuticals, Inc.
February 27, 2024
From
Virpax Pharmaceuticals, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Wednesday's After-Market Session
February 21, 2024
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
February 19, 2024
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
February 16, 2024
Via
Benzinga
Virpax Pharmaceuticals Announces Preliminary Results of ProbudurTM Pilot Study with the U.S. Army Institute of Surgical Research
February 07, 2024
From
Virpax Pharmaceuticals, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Wednesday's After-Market Session
January 17, 2024
Via
Benzinga
Virpax Pharmaceuticals Announces Results of Special Shareholders Meeting
December 29, 2023
From
Virpax Pharmaceuticals, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Friday's After-Market Session
December 15, 2023
Via
Benzinga
Why Quanex Building Products Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
December 15, 2023
Shares of Quanex Building Products Corporation (NYSE: NX) moved lower during Friday’s session after the company reported fourth-quarter financial results. Quanex Building Products shares fell 10.7% to...
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
December 15, 2023
Via
Benzinga
Why Getaround Shares Are Trading Higher By Around 86%; Here Are 20 Stocks Moving Premarket
December 15, 2023
Shares of Getaround, Inc. (NYSE: GETR) rose sharply in pre-market trading after the company reported a year-over-year increase in third-quarter financial results.
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
December 15, 2023
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
December 15, 2023
It's time to dive into the biggest pre-market stock movers for Friday morning as we check out the winners and losers today!
Via
InvestorPlace
12 Health Care Stocks Moving In Thursday's After-Market Session
December 14, 2023
Via
Benzinga
Why Daktronics Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
December 05, 2023
Shares of Daktronics, Inc. (NASDAQ: DAKT) moved lower during Tuesday’s session following weak quarterly results.
Via
Benzinga
Why GitLab Shares Are Trading Higher By Over 16%; Here Are 20 Stocks Moving Premarket
December 05, 2023
Shares of GitLab Inc. (NASDAQ: GTLB) rose sharply in pre-market trading after the company posted better-than-expected results for its third quarter and issued a stro
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
December 04, 2023
Via
Benzinga
Virpax Pharmaceuticals Announces Notification from Nasdaq Related to Delayed Form 10-Q Filing
November 17, 2023
From
Virpax Pharmaceuticals
Via
Business Wire
Virpax Pharmaceuticals Announces Leadership Transition
November 17, 2023
From
Virpax Pharmaceuticals, Inc.
Via
Business Wire
Virpax Pharmaceuticals Reports 2023 Third Quarter Results and Recent Developments
November 15, 2023
From
Virpax Pharmaceuticals, Inc.
Via
Business Wire
Virpax Pharmaceuticals Announces that Envelta™ Remains on Track for Trial in Humans Following FDA Review
October 31, 2023
From
Virpax Pharmaceuticals
Via
Business Wire
12 Health Care Stocks Moving In Friday's After-Market Session
October 27, 2023
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
October 17, 2023
Via
Benzinga
Virpax Pharmaceuticals Announces Extension of CRADA with the U.S. Army Institute of Surgical Research
October 12, 2023
From
Virpax Pharmaceuticals, Inc.
Via
Business Wire
Gerald W. Bruce Appointed President and CEO of Novvae™ Pharmaceuticals
October 02, 2023
From
Virpax Pharmaceuticals
Via
Business Wire
Virpax Pharmaceuticals Announces Results of Probudur™ Dose Escalation Studies
September 27, 2023
From
Virpax Pharmaceuticals, Inc.
Via
Business Wire
Virpax Pharmaceuticals to Present at the LD Micro Main Event XVI
September 26, 2023
From
Virpax Pharmaceuticals, Inc.
Via
Business Wire
Altasciences Chosen by Virpax to Support the Development of a New Drug to Prevent Spread of Flu-like Viruses
September 21, 2023
From
Altasciences
Via
Business Wire
Virpax Pharmaceuticals Announces the Formation of Novvae™ Pharmaceuticals
September 18, 2023
From
Virpax Pharmaceuticals
Via
Business Wire
< Previous
1
2
3
4
5
6
7
8
9
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.